Technology

Taro

$77.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.98 (+1.29%) Today
$0.00 (0.00%) As of 1:33 PM UTC after-hours

Why Robinhood?

You can buy or sell Taro and other stocks, options, and ETFs commission-free!

About TARO

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel. The listed name for TARO is Taro Pharmaceutical Industries Ltd.

CEO
Uday Vijaykumar Baldota
Employees
1,464
Headquarters
Haifa Bay, Haifa
Founded
1950
Market Cap
2.93B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
24.24K
High Today
$77.67
Low Today
$75.33
Open Price
$75.33
Volume
14.04K
52 Week High
$85.11
52 Week Low
$53.95

Collections

TARO Earnings

$0.00
$0.65
$1.31
$1.96
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Jan 27, After Hours

You May Also Like

IBM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure